EverSource Wealth Advisors LLC Significantly Increased Holdings in Recursion Pharmaceuticals, Inc.

Summary

EverSource Wealth Advisors LLC significantly increased its stake in Recursion Pharmaceuticals, Inc. (NASDAQ: RXRX) by 94,360% in Q1, owning 108,629 shares valued at $575,000. Other institutional investors also raised their stakes, with notable increases from Man Group PLC and Rockefeller Capital Management. Recursion Pharmaceuticals’ stock is currently trading at $5.77, with a market cap of $2.51 billion. The company reported a quarterly revenue of $19.10 million but missed EPS estimates, reflecting a negative net margin of 1,004.91%. Analysts have mixed ratings on the stock, with an average target price of $7.00.Market Beat

Impact Analysis

This is a company-level event, given that it specifically pertains to Recursion Pharmaceuticals and its investment dynamics. The significant increase in stake by EverSource Wealth Advisors LLC, along with other institutional investors like Man Group PLC and Rockefeller Capital Management, suggests confidence in Recursion Pharmaceuticals’ long-term potential despite recent financial struggles, such as missing EPS estimates and having a negative net margin.Market Beat The stock is currently trading below its average target price of $7.00, which may present a buying opportunity for investors anticipating future growth. The recent financial results show challenges, like increased net loss, which could pose risks if the company cannot turn these around.Simplywall Investors should consider these factors along with the mixed analyst ratings when evaluating potential investment opportunities in RXRX.